Unknown

Dataset Information

0

A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.


ABSTRACT: Recent advancements in T cell immunotherapy suggest that T cells engineered with high-affinity TCR can offer better tumor regression. However, whether a high-affinity TCR alone is sufficient to control tumor growth, or the T cell subset bearing the TCR is also important remains unclear. Using the human tyrosinase epitope-reactive, CD8-independent, high-affinity TCR isolated from MHC class I-restricted CD4(+) T cells obtained from tumor-infiltrating lymphocytes (TIL) of a metastatic melanoma patient, we developed a novel TCR transgenic mouse with a C57BL/6 background. This HLA-A2-restricted TCR was positively selected on both CD4(+) and CD8(+) single-positive cells. However, when the TCR transgenic mouse was developed with a HLA-A2 background, the transgenic TCR was primarily expressed by CD3(+)CD4(-)CD8(-) double-negative T cells. TIL 1383I TCR transgenic CD4(+), CD8(+), and CD4(-)CD8(-) T cells were functional and retained the ability to control tumor growth without the need for vaccination or cytokine support in vivo. Furthermore, the HLA-A2(+)/human tyrosinase TCR double-transgenic mice developed spontaneous hair depigmentation and had visual defects that progressed with age. Our data show that the expression of the high-affinity TIL 1383I TCR alone in CD3(+) T cells is sufficient to control the growth of murine and human melanoma, and the presence or absence of CD4 and CD8 coreceptors had little effect on its functional capacity.

SUBMITTER: Mehrotra S 

PROVIDER: S-EPMC3674773 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Recent advancements in T cell immunotherapy suggest that T cells engineered with high-affinity TCR can offer better tumor regression. However, whether a high-affinity TCR alone is sufficient to control tumor growth, or the T cell subset bearing the TCR is also important remains unclear. Using the human tyrosinase epitope-reactive, CD8-independent, high-affinity TCR isolated from MHC class I-restricted CD4(+) T cells obtained from tumor-infiltrating lymphocytes (TIL) of a metastatic melanoma pati  ...[more]

Similar Datasets

| S-EPMC6220888 | biostudies-other
| S-SCDT-EMBOJ-2022-110636 | biostudies-other
| S-EPMC5440033 | biostudies-literature
| S-EPMC2976765 | biostudies-literature
| S-EPMC3594800 | biostudies-literature
2024-05-21 | PXD044245 | Pride
| S-EPMC8783116 | biostudies-literature
| S-EPMC7417304 | biostudies-literature
| S-EPMC7053418 | biostudies-literature
| S-EPMC7640589 | biostudies-literature